Hikma Pharmaceuticals PLC (HIK)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
1,944.00p
Buy
1,946.00p
-14.00p (-0.71%)
Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.
Prices updated at 31 Mar 2025, 17:00 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
In the news
Sharecast service unavailable
Press releases
19 Mar 202504 Mar 202526 Feb 202510 Feb 202523 Dec 202407 Nov 202407 Nov 202424 Oct 202401 Oct 202424 Sep 2024
Key dates
| Forecast date | |
|---|---|
| Annual report | Mar 2026 |
| Final results | Feb 2026 |
| Half yearly results | Aug 2025 |
| Annual general meeting | Apr 2025 |
| Previous date | |
|---|---|
| Annual report | Mar 2025 |
| Final results | Feb 2025 |
| Half yearly results | Aug 2024 |
| Annual general meeting | Apr 2024 |
Company reports
31 Dec 2023
Annual Report 31 Dec 2023
Quarterly Report 